» Articles » PMID: 19526304

Prevalence of Anemia According to Stage of Chronic Kidney Disease in a Large Screening Cohort of Japanese

Overview
Publisher Springer
Specialty Nephrology
Date 2009 Jun 16
PMID 19526304
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalence of chronic kidney disease (CKD) is high in developed countries, including Japan. However, little is known about the prevalence of anemia according to the estimated glomerular filtration rate (eGFR) among Japanese.

Methods: We studied screenees on the Okinawa General Health Maintenance Association (OGHMA) registry in 1993 (N = 94,602; 54,848 women and 39,754 men) who had both serum creatinine and hematocrit data. Anemia was defined as follows: hematocrit level <40% in men, <32% in women aged <50 years, and <35% in women aged >or=50 years. GFR was estimated using a new Japanese equation: eGFR (ml/min per 1.73 m(2)) = 194 x serum creatinine(1.094) x age(0.287) x 0.739 (if female).

Results: The prevalence of anemia clearly increased as CKD progressed below an eGFR of 60 ml/min per 1.73 m(2) in both genders. Logistic analysis adjusted with body mass index and older age (>or=70 years) revealed that the odds ratio for complications of anemia was significantly increased below an eGFR of 45 ml/min per 1.73 m(2) in women and 90 ml/min per 1.73 m(2) in men. The association of lower kidney function with anemia was found to be more prevalent: adjusted odds ratio >or=2.0, from approximately 50 ml/min per 1.73 m(2).

Conclusion: The present study suggested that there might be as many as 1,000,000 people with CKD stage 3-5 complicated with anemia in Japan.

Citing Articles

Prevalence of anemia and associated All-Cause mortality among adults with Diabetes: The role of chronic kidney disease.

Koyama A, Lundeen E, Bullard K, Pavkov M Diabetes Res Clin Pract. 2023; 200:110695.

PMID: 37156427 PMC: 10701781. DOI: 10.1016/j.diabres.2023.110695.


Estimating the causal effect of transient anemia status on renal and cardiovascular outcomes in community-dwelling patients in Japan at the beginning of impaired renal function using marginal structural modeling.

Onozawa S, Kimura T, Ito Y, Akizawa T Clin Exp Nephrol. 2021; 26(2):178-189.

PMID: 34596791 PMC: 8770383. DOI: 10.1007/s10157-021-02137-1.


Molidustat for the treatment of anemia in Japanese patients undergoing peritoneal dialysis: a single-arm, open-label, phase 3 study.

Akizawa T, Nobori K, Matsuda Y, Taki K, Hayashi Y, Hayasaki T Ther Apher Dial. 2021; 26(2):368-377.

PMID: 34310049 PMC: 9290504. DOI: 10.1111/1744-9987.13713.


Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open-label study in Japan.

Nangaku M, Kondo K, Takabe S, Ueta K, Kaneko G, Otsuka M Ther Apher Dial. 2020; 25(5):642-653.

PMID: 33283981 PMC: 8451920. DOI: 10.1111/1744-9987.13611.


Risk of Anemia in Patients with Newly Identified Chronic Kidney Disease - A Population-Based Cohort Study.

Vestergaard S, Heide-Jorgensen U, van Haalen H, James G, Hedman K, Birn H Clin Epidemiol. 2020; 12:953-962.

PMID: 32982460 PMC: 7494011. DOI: 10.2147/CLEP.S259648.


References
1.
Fehr T, Ammann P, Garzoni D, Korte W, Fierz W, Rickli H . Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia. Kidney Int. 2004; 66(3):1206-11. DOI: 10.1111/j.1523-1755.2004.00880.x. View

2.
Singh A, Szczech L, Tang K, Barnhart H, Sapp S, Wolfson M . Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006; 355(20):2085-98. DOI: 10.1056/NEJMoa065485. View

3.
Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

4.
Muntner P, He J, Astor B, Folsom A, Coresh J . Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2004; 16(2):529-38. DOI: 10.1681/ASN.2004080656. View

5.
Hsu C, Bates D, Kuperman G, Curhan G . Relationship between hematocrit and renal function in men and women. Kidney Int. 2001; 59(2):725-31. DOI: 10.1046/j.1523-1755.2001.059002725.x. View